Dextrose Injection, Solution
Product Images NDC 0409-7100

11 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0409-7100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig.1 And Fig. 2 (Dextrose01)

Fig.1 And Fig. 2 (Dextrose01)
Illustrations showing instructions for removing a tamper-evident ring from a bottle cap. Fig. 1 depicts a hand pulling the ring down to snap it off the cap. Fig. 2 shows the ring detached, with the cap being lifted upward and twisted off the bottle.*
FDA Label Image

Fig. 3 (Dextrose02)

Fig. 3 (Dextrose02)
An instructional line drawing showing a hand manipulating the cap on the top of a medical IV bag. The IV bag has a port at the bottom and fluid level markings on the front. This illustration likely depicts preparation or use of an intravenous solution container.*
FDA Label Image

Fig 4 (Dextrose03)

Fig 4 (Dextrose03)
Illustration showing a hand holding a vial above an intravenous solution bag, demonstrating the transfer or attachment technique for fluid administration.*
FDA Label Image

Fig 5 Fig 6 And Fig 7 (Dextrose04)

Fig 5 Fig 6 And Fig 7 (Dextrose04)
An instructional illustration showing three steps (Figures 5, 6, and 7) for handling or preparing an intravenous injection solution bag. The images depict hands manipulating parts of the solution bag, likely demonstrating how to open, access, or activate the container before use.*
FDA Label Image

Structural Formula Dextrose (Dextrose05)

Structural Formula Dextrose (Dextrose05)
Chemical structure of dextrose monohydrate showing the glucose ring form with hydroxyl groups and an attached water molecule (H2O) representing the monohydrate form.*
FDA Label Image

Hospira Logo (Dextrose06)

FDA Label Image

Principal Display Panel (50 mL Bag Label)

Principal Display Panel (50 mL Bag Label)
Label for Dextrose 5% Injection, USP, 50 mL solution for intravenous use. The label indicates the drug contains dextrose monohydrate at 5% strength (50 mg/mL) with detailed instructions for use, and is distributed by Hospira, Inc. The label includes NDC 0409-7100, mixing instructions, and areas designated for lot number and expiration dating.*
FDA Label Image

Principal Display Panel (100 mL Bag Label)

Principal Display Panel (100 mL Bag Label)
Label for Dextrose 5% Injection, USP, 100 mL intravenous solution by Hospira, Inc. The label indicates the active ingredient as dextrose monohydrate at 5% concentration, with detailed instructions including 'PULL INNER PLUG/STOPPER AND MIX DRUG BEFORE USE.' The label includes NDC 0409-7100-69 and notes that the product is sterile and single-dose. Distribution information lists Hospira, Inc., Lake Forest, IL.*
FDA Label Image

Principal Display Panel (250 mL Bag Label)

Principal Display Panel (250 mL Bag Label)
Label for 5% Dextrose Injection, USP, 250 mL intravenous solution by Hospira, Inc. The label includes instructions to pull the inner plug/stopper and mix the drug before use. It provides drug concentration details, usage warnings, storage symbols, and distributor information.*
FDA Label Image

Principal Display Panel (OVERWRAP – WR-0583)

Principal Display Panel (OVERWRAP – WR-0583)
Label for a Hospira, Inc. injection solution of Dextrose monohydrate 50 mg/mL for intravenous use. Instructions note the product is an ADD-Vantage Unit to be opened by peeling at the corner, for use only with ADD-Vantage system components. The label includes storage conditions, handling instructions, and a reminder to check for leaks after removing the overwrap. The product is prescription only.*
FDA Label Image

Principal Display Panel (OVERWRAP – WR-0581)

Principal Display Panel (OVERWRAP – WR-0581)
Label for Five/ADD-Vantage Units by Hospira, Inc., specifying use only with ADD-Vantage system components. Includes storage instructions, moisture barrier notice, and a directive to use units within 30 days after opening the overwrap, with temperature details. Distributed by Hospira, Inc., Lake Forest, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.